A phantom human chorionic gonadotropin in the case of molar pregnancy.
false-positive hCG
heterophilic antibody
hydatidiform mole
phantom hCG
trophoblastic disease
urine hCG
Journal
Oxford medical case reports
ISSN: 2053-8855
Titre abrégé: Oxf Med Case Reports
Pays: England
ID NLM: 101642070
Informations de publication
Date de publication:
May 2024
May 2024
Historique:
received:
18
10
2023
revised:
25
01
2024
accepted:
19
03
2024
medline:
24
5
2024
pubmed:
24
5
2024
entrez:
24
5
2024
Statut:
epublish
Résumé
Accurately interpreting persistent, low human chorionic gonadotropin (hCG) levels is essential for managing gestational trophoblastic disease. Erroneous interpretation can lead to inappropriate interventions, including unnecessary chemotherapy or hysterectomy, or unjustified changes in chemotherapeutic regimens due to misidentification of a false-positive hCG as a true positive. The predominant etiology of phantom hCG is the presence of heterophilic antibodies. Consequently, screening for urine hCG is indispensable for its diagnosis because immunoglobulin is not generally present in urine. Here, we report about phantom hCG after a complete hydatidiform mole. Initial urine hCG evaluations were negative, although the serum hCG levels remained positive, leading to the diagnosis of phantom hCG. After subsequent delivery, urine hCG levels persisted at diminished levels. However, a different assay yielded negative hCG results for both serum and urine samples. The patient subsequently gave birth. The absence of hCG was consistently confirmed over five years.
Identifiants
pubmed: 38784771
doi: 10.1093/omcr/omae038
pii: omae038
pmc: PMC11110852
doi:
Types de publication
Case Reports
Langues
eng
Pagination
omae038Informations de copyright
© The Author(s) 2024. Published by Oxford University Press.
Déclaration de conflit d'intérêts
None.